Kirsten Greene

Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).

Laparoscopic-assisted upper pole ureterocalicostomy using renal inversion and autotransplantation.

CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.

Who is the average patient presenting with prostate cancer?

Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility.

Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE.

The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.

Traditional Foley drainage systems--do they drain the bladder?

Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer.

Prostate specific antigen best practice statement: 2009 update.

Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.

Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.

The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer.

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.

Prostate specific antigen best practice statement: 2009 update.

How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?

Proximal bulbar periurethral abscess.

Early detection of prostate cancer: AUA Guideline.

Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.

MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.

Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates.

Evolution and immediate future of US screening guidelines.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.

Patterns of Local Failure following Radiation Therapy for Prostate Cancer.

Intravesical chemotherapy in non-muscle-invasive bladder cancer.

The argument for palliative care in prostate cancer.

Identifying Prevalence and Risk Factors for Mild Cognitive Impairment in Adults Presenting for Urological Evaluation.

Targeted PET imaging for prostate-specific membrane antigen in prostate cancer.

Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.